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Burns are among the most challenging injuries to manage. 
Although the great advances in treatment that have been 
made have arguably been sufficient to address the related 
medical challenges of  the past century, modern society 
now faces even greater difficulties. These are caused pre-
dominantly by increase in population and lifespan, which 
frequently are not matched by an increased effectiveness in 
the maintenance of  health and quality of  life.
Because aging people are more prone to illness, keeping 
people healthy and active, while managing healthcare 
costs, is an important societal challenge. The ethical and 
economic dilemma is how to achieve equality in quality of  
care while simultaneously decreasing the cost of  care for 
an ever-expanding number of  people.
Burn injuries, leading to significant mortality and mor-
bidity all over the word, are among the most devastating 
of  all injuries, with outcomes varying from physical 
impairments and disabilities to emotional and mental 
consequences. The management of  burns and their se-
quelee, even in the well-equipped, modern burn units of  
advanced and affluent societies, remains demanding and 
extremely costly.[1]
Consequently, considerable effort is needed to define an 
appropriate strategy for the successful implementation of  
therapeutic treatments in terms of  performance and cost. In 
the context of  these complex needs, biomaterials and related 
novel technologies may play an important role because it 
is possible to precisely customize their overall properties.
Generally, burns cause significant fluid loss and extensive 
tissue damage resulting from deep wounds by impairing 
many of  the vital functions performed by the skin. Wound 
infection, which further exacerbates the local tissue dam-
age, is a common complication, and systemic inflammatory 
and immunological responses can arise that may lead to 
a higher predisposition toward life-threatening sepsis and 
multi-organ failure.[2] In such cases, easy and appropriate 
clinical treatments are critical to reduce the mortality rates 
associated with the injury.
These considerations suggest an expanded emphasis on 
the following to satisfy the growing need for effective burn 
treatment:
1. Regeneration of  tissues, and
2. Prevention of  tissue deterioration.
This note outlines the clinical needs that could be met by 
innovative bioactive materials in the near future, including 
the repair and regeneration of  soft tissues and the rapid, 
low-cost analysis of  human cell-biomaterial interactions 
leading to patient-specific diagnoses and treatments using 
molecularly tailored biomaterials.
Various therapies that effect wound repair have been pro-
posed over the past few decades. The innovative application 
of  bioactive materials with genetic control of  in situ tissue 
responses offers the potential to achieve both tissue regen-
eration and prevention of  tissue deterioration. The clinical 
success of  the use of  bioactive biomaterials for regeneration 
provides evidence that this approach is effective; likewise, 
there is evidence that the prevention of  tissue deterioration 
is also possible.
Bioengineered products that can facilitate the healing of  
chronic ulcers, deep wounds, and burns are in increased 
demand to improve patients’ quality of  life and survival 
rate. Many different biomaterials have been investigated 
for the use as dermal substitutes[3] and no material has yet 
been described that provides fulfils all the ideal features for 
such a purpose.
The clinical performance of  wound dressings and dermal 
substitutes based on synthetic biomaterials is limited by 
the ability of  these polymers to keep the wound environ-
ment moist, to protect the wound site from infections, and, 
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in some cases, to encourage cell colonization.[4,5] Natural 
polymers of  human and animal origin exhibit biochemi-
cal features that can facilitate the healing process. Indeed, 
biomaterials based on protein or polysaccharide compo-
sitions, such as collagen, glycosaminoglycans, agarose, 
alginate, chitosan, and fibrin glue, have been shown to be 
able to promote interactions with biochemical and cellular 
components, leading, for example, to hemostatic functions 
(e.g., alginate and fibrin) and to bioligand-driven cell-activity 
control (e.g., collagen and hyaluronan).[6] In this issue, the 
article by Longinotti discusses the role of  hyaluronic acid 
in skin tissue formation and wound healing, and the use of  
hyaluronic acid (HA) based dressings and dermal substitutes 
is reviewed, especially the successful clinical application of  
HYAFF® film, a commercial medical device.[7] Natural poly-
mers from plants and marine organism, such as vegetable 
proteins, cellulose, chitosan, etc., have also been studied as 
wound dressing materials. The article entitled “Pre-clinical 
evaluation of  soybean-based wound dressings and dermal 
substitute formulations in pig healing and non-healing in 
vivo models” by Shevchenko and Santin, demonstrates the 
function of  such materials in wound healing and the im-
portance of  choosing optimized formulations for different 
situations.[8] However, the use of  biopolymers in regenera-
tive medicine is limited by their antigenic potential, by the 
risk of  transmittable diseases, and, in some cases, by their 
relatively high extraction costs.
Initially, raw human or animal skin, either fresh or frozen, 
was used to cover wounds but immunological reactions 
were soon observed leading to poor experimental and 
clinical performances. These demonstrated no rejection 
upon implantation while providing a solid dermal wound 
bed for the later application of   split-thickness skin grafts. [9]
Although this approach has been clinically successful, it still 
suffers certain drawbacks that must be resolved.
A class of  therapies is emerging that is based on gene and 
stem cell therapy. Gene therapy, which was initially devel-
oped to treat congenital defects, is a newly viable option 
for the enhancement of  wound repair. Gene encoding for 
growth factors or cytokines has shown the greatest potential 
in accelerating wound closure. Most of  the gene-delivery 
systems are on the basis of  naked DNA application, high-
pressure injection, viral transfection, or liposomal vectors. 
Stem cell therapy is based on the prolonged capacity of  em-
bryonic and adult stem cells that can differentiate into vari-
ous tissue types. Stem cells isolated from various sources, 
including bone marrow, umbilical cord blood, peripheral 
blood, adipose tissue, skin, and hair follicles, have been 
used to accelerate the wound healing process of  acute and 
chronic wounds.[10]
In this issue, Wang et al. introduce the use of  collagen-
binding MSC affinity peptide as a scaffold in treating acute 
full-thickness skin wounds in vivo. The scaffold demon-
strated the ability to capture MSCs to injury sites and to 
accelerate wound healing.[11] Recently, the combination of  
gene and stem cell therapy has become a promising way 
to treat acute and chronic wounds, though it remains at an 
experimental level. 
The engineering of  dermal substitutes and their application 
in human patients has come into reality.[7] However, sur-
geons, materials scientists, biochemists and biologists,  are 
still striving to develop complex biomimetic skin substitutes 
which can be readily used in large quantities, possibly in 
only one surgical intervention and without obvious scarring. 
The ambitious goal is now to construct a dermoepidermal 
substitute that can get rapid vascularization, optimally 
supports a stratifying epidermal graft on a biodegradable 
matrix, and can be easily handled by the surgeon. After all, 
this goal must be achieved in compliance with both strict 
safety requirements and the harsh realities of  the economic 
market.[12]
Nanotechnologies and nanomaterials have introduced new 
therapeutic horizons in medical research, and innovative 
technologies are rapidly advancing for the development of  
novel bioactive materials for burn-wound care that are able 
to mimic the extracellular matrix, including its structure, 
biological cues, cells, and biofunctionality. Moreover, ef-
forts in the development of  novel strategies for modifying 
the nanotopography of  surfaces have recently been ap-
plied to the fabrication of  new generations of  bactericidal 
biomaterials through surface coatings or surface-chemical 
modifications.[13]
Hydrogels/gels and related composites appear to be opti-
mal biomaterials for burn management that employ both 
regenerative and reparative strategies. Because of  their 
intrinsic structure, hydrogels and gels prevent the presence 
of  excessive exudates in the wound while also, contributing 
to the digestion of  eschar and necrotic tissue. They enable 
the following:
1. The inclusion of  nanofibers to fulfill structural needs;
2. The inclusion of  nano- and/or microspheres to include 
biological cues, for both regenerative and therapeutic 
needs, to induce delivery on demand;
3. The inclusion of  specific cells for optimal regeneration;
4. The modulation of  the nano- and microporosity of  the 
materials to promote angiogenesis and reinnervation;
5. Surface-chemical modification to achieve anti-adhesive 
and antimicrobial effects; and
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6. Biodegradability. The use of  polymeric hydrogels as 
advanced skin wound dressings and regenerative tem-
plates in wound care is reviewed by Madaghiel et al. in 
this issue. This review contributes to the understanding 
of  the functions of  polymeric hydrogels, as well as the 
research and application of  hydrogels for wound heal-
ing.[14]
Conclusions
There is considerable potential for hydrogels and polymer-
based materials to facilitate the achievement of  better treat-
ment for burn injuries without neglecting healthcare needs. 
However, for the implementation of   this approach, several 
aspects should be considered:
1. Research and product development should be directed 
toward specific clinical needs;
2. A knowledge systemic approach should be taken, fos-
tered by the integration of  various disciplines based on 
key enabling technologies; and
3. Appropriate actions should always consider the mental, 
social, and physical health of  the patient.
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